Retrospective analysis of the safety profile and clinical, radiological and PSA evolution in metastatic castration resistant prostate cancer (MCRPC), chemotherapy naïve patients treated with abiratarone acetate (AA)
Autor: | Couselo Paniagua, M., López Carrizosa, M., Samper Ots, P., Zapatero Ortuño, J., Jerviz Guía, V., Ibañez Villoslada, C., Saez Garrido, J., Dominguez Morcillo, M., Martin de Miguel, M. |
---|---|
Zdroj: | In Reports of Practical Oncology & Radiotherapy June 2013 18 Supplement 1:S333-S333 |
Databáze: | ScienceDirect |
Externí odkaz: |